11-113410767-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000795.4(DRD2):āc.1292T>Cā(p.Ile431Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_000795.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRD2 | NM_000795.4 | c.1292T>C | p.Ile431Thr | missense_variant | 8/8 | ENST00000362072.8 | NP_000786.1 | |
DRD2 | NM_016574.4 | c.1205T>C | p.Ile402Thr | missense_variant | 7/7 | NP_057658.2 | ||
DRD2 | XM_017017296.3 | c.1292T>C | p.Ile431Thr | missense_variant | 8/8 | XP_016872785.1 | ||
DRD2 | XM_047426511.1 | c.1205T>C | p.Ile402Thr | missense_variant | 7/7 | XP_047282467.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251448Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135890
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.0000633 AC XY: 46AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.1292T>C (p.I431T) alteration is located in exon 8 (coding exon 7) of the DRD2 gene. This alteration results from a T to C substitution at nucleotide position 1292, causing the isoleucine (I) at amino acid position 431 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dystonic disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 431 of the DRD2 protein (p.Ile431Thr). This variant has not been reported in the literature in individuals affected with DRD2-related conditions. This variant is present in population databases (rs376186482, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at